About Ali Aldujeli
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ali Aldujeli
During the past decade, Ali Aldujeli conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2013-10-01
2016-04-01
Completed
711
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
2014-10-06
2015-08-21
Completed
908
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
2015-09-01
2017-04-04
Completed
572
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ali Aldujeli"
#1 collaborator was "Baylor Scott and White Health" with 1 trials as a collaborator, "Kreiskrankenhaus Rotenburg" with 1 trials as a collaborator, "Minneapolis Heart Institute" with 1 trials as a collaborator and "Università degli Studi di Brescia" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Ali Aldujeli
According to Clinical.Site data, the most researched conditions in "Ali Aldujeli" are
"Cardiopulmonary Arrest" (1 trials), "Epinephrine Causing Adverse Effects in Therapeutic Use" (1 trials), "Microvascular Coronary Artery Disease" (1 trials) and "STEMI - ST Elevation Myocardial Infarction" (1 trials). Many other conditions were trialed in "Ali Aldujeli" in a lesser frequency.
Clinical Trials Intervention Types at Ali Aldujeli
Most popular intervention types in "Ali Aldujeli" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Epinephrin" (1 trials) and "pressure-temperature sensor guidewire-based measurement" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ali Aldujeli
The vast majority of trials in "Ali Aldujeli" are
2 trials for "All" genders.
Clinical Trials Status at Ali Aldujeli
Currently, there are NaN active trials in "Ali Aldujeli".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Ali Aldujeli,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ali Aldujeli, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".